An SPS Quality Assurance (QA) bite size learning event on deviation investigation and establishing root causes in pharmacy aseptic services. 27 June 2025.
Discussion about implementing biosimilar insulin in primary care: key considerations, hints, and tips for systems planning the transition. 10 June 2025.
There are many artificial saliva products for dry mouth (xerostomia). We summarise eligibility for dental prescribing and key pharmaceutical considerations.
Artificial saliva products for dry mouth (xerostomia) vary in formulation. We advise on pharmaceutical considerations and prescribing or supplying in dentistry.
Advice on the management of PGDs when organisations merge, cease to exist or services are transferred to a new provider to ensure safe care and good governance
An SPS Quality Assurance (QA) bite size learning event on deviation investigation and establishing root causes in pharmacy aseptic services. 27 June 2025.
Discussion about implementing biosimilar insulin in primary care: key considerations, hints, and tips for systems planning the transition. 10 June 2025.
There are many artificial saliva products for dry mouth (xerostomia). We summarise eligibility for dental prescribing and key pharmaceutical considerations.
Artificial saliva products for dry mouth (xerostomia) vary in formulation. We advise on pharmaceutical considerations and prescribing or supplying in dentistry.
Advice on the management of PGDs when organisations merge, cease to exist or services are transferred to a new provider to ensure safe care and good governance
These are the detailed and easy read summary reports of the northern pharmacy technical services (PTS) workforce project. They provide a critical analysis of the…
This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…